Randomized trials suggest adjuvant chemotherapy is effective for elderly patients with stage III colon cancer. However, the elderly are less likely to receive this therapy than younger patients, perhaps because of concern about adverse effects
Summary: Background: There have been few previous studies regarding survival and predictive factors...
Background: Many older patients don't receive appropriate oncological treatment. Our aim was to anal...
In randomized trials, patients with stage III colon cancer who received 6 months of fluorouracil (FU...
CONTEXT: Randomized trials suggest adjuvant chemotherapy is effective for older patients with stage ...
Few patients 75 years of age and older participate in clinical trials, thus whether adjuvant chemoth...
BACKGROUND: Although the benefit from adjuvant chemotherapy has been established clearly in patients...
Background: Adjuvant. 5-fluoruracil-based chemotherapysignificantly reduces mortality in. patients w...
Owing to poor representation in trials, the optimum adjuvant regimen for elderly patients with stage...
BACKGROUND: Adjuvant chemotherapy is standard treatment for patients with resected colon cancer who...
PURPOSE: Adjuvant chemotherapy has been known as a standard treatment for patients with resected col...
Objective: Colorectal cancer is the third most commonly reported cancer in the world and about 50% o...
Owing to poor representation in trials, the optimum adjuvant regimen for elderly patients with stage...
Background We evaluated which patient factors were associated with treatment tolerance and outcome i...
Introduction: We assessed whether older patients experience the same treatment benefits from adjuvan...
We determined to what extent patients with colon cancer stage III >= 75 years received adjuvant chem...
Summary: Background: There have been few previous studies regarding survival and predictive factors...
Background: Many older patients don't receive appropriate oncological treatment. Our aim was to anal...
In randomized trials, patients with stage III colon cancer who received 6 months of fluorouracil (FU...
CONTEXT: Randomized trials suggest adjuvant chemotherapy is effective for older patients with stage ...
Few patients 75 years of age and older participate in clinical trials, thus whether adjuvant chemoth...
BACKGROUND: Although the benefit from adjuvant chemotherapy has been established clearly in patients...
Background: Adjuvant. 5-fluoruracil-based chemotherapysignificantly reduces mortality in. patients w...
Owing to poor representation in trials, the optimum adjuvant regimen for elderly patients with stage...
BACKGROUND: Adjuvant chemotherapy is standard treatment for patients with resected colon cancer who...
PURPOSE: Adjuvant chemotherapy has been known as a standard treatment for patients with resected col...
Objective: Colorectal cancer is the third most commonly reported cancer in the world and about 50% o...
Owing to poor representation in trials, the optimum adjuvant regimen for elderly patients with stage...
Background We evaluated which patient factors were associated with treatment tolerance and outcome i...
Introduction: We assessed whether older patients experience the same treatment benefits from adjuvan...
We determined to what extent patients with colon cancer stage III >= 75 years received adjuvant chem...
Summary: Background: There have been few previous studies regarding survival and predictive factors...
Background: Many older patients don't receive appropriate oncological treatment. Our aim was to anal...
In randomized trials, patients with stage III colon cancer who received 6 months of fluorouracil (FU...
DOI
Add to ORKG